---
title: "Jingfeng Pharmaceutical's Unit Gets Registration Certificate for Montelukast Sodium Chewable Tablets"
date: "2025-02-11 13:53:22"
summary: "Hunan Jingfeng Pharmaceutical's  unit, Hainan Jinrui Pharmaceutical, obtained a drug registration certificate from China's National Medical Products Administration for Montelukast sodium chewable tablets, according to a Shenzhen Stock Exchange disclosure on Tuesday. The drug is used to treat asthma and allergic rhinitis in children, the pharmaceutical company said."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Hunan Jingfeng Pharmaceutical's unit, Hainan Jinrui Pharmaceutical, obtained a drug registration certificate from China's National Medical Products Administration for Montelukast sodium chewable tablets, according to a Shenzhen Stock Exchange disclosure on Tuesday.

The drug is used to treat asthma and allergic rhinitis in children, the pharmaceutical company said.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:G2466066:0/)
